These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 31807049)

  • 21. Association of IL28B SNP With Progression of Egyptian HCV Genotype 4 Patients to End Stage Liver Disease.
    El-Awady MK; Mostafa L; Tabll AA; Abdelhafez TH; Bader El Din NG; Zayed N; Shenawy RE; El Abd Y; Hasan RM; Zaghlol H; El Khayat H; Abdel Aziz AO
    Hepat Mon; 2012 Apr; 12(4):271-7. PubMed ID: 22690235
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The complete title: The effect of interleukin-28B rs12979860 polymorphism on the therapeutic response of Moroccan patients with chronic hepatitis C.
    Nadia K; Hicham E; Reda TM; Nadia T; Elarbi B; Saâd E; Mimoun Z; Saâd M
    Gene; 2015 Aug; 568(1):31-4. PubMed ID: 25958342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polymorphism rs368234815 of interferon lambda 4 gene and spontaneous clearance of hepatitis C virus in haemodialysis patients: a case-control study.
    Grzegorzewska AE; Mostowska A; Świderska MK; Marcinkowski W; Stolarek I; Figlerowicz M; Jagodziński PP
    BMC Infect Dis; 2021 Jan; 21(1):102. PubMed ID: 33482747
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of host IL28B rs12979860, rs8099917 in interferon responsiveness and advanced liver disease in chronic genotype 3 hepatitis C patients.
    Firdaus R; Biswas A; Saha K; Mukherjee A; Chaudhuri S; Chandra A; Konar A; Sadhukhan PC
    PLoS One; 2014; 9(6):e99126. PubMed ID: 24914551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IFNL3 (IL28B) and IFNL4 polymorphisms are associated with treatment response in Thai patients infected with HCV genotype 1, but not with genotypes 3 and 6.
    Akkarathamrongsin S; Thong VD; Payungporn S; Poovorawan K; Prapunwattana P; Poovorawan Y; Tangkijvanich P
    J Med Virol; 2014 Sep; 86(9):1482-90. PubMed ID: 24782280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic Polymorphism of MTHFR C677T Influences Susceptibility to HBV-Related Hepatocellular Carcinoma in a Chinese Population: a Case-Control Study.
    Qiao K; Zhang S; Trieu C; Dai Q; Huo Z; Du Y; Lu W; Hou W
    Clin Lab; 2017 Apr; 63(4):787-795. PubMed ID: 28397480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin-28 and hepatitis C virus genotype-4: treatment-induced clearance and liver fibrosis.
    Derbala M; Rizk N; Shebl F; Alkaabi S; Eldweik N; John A; Sharma M; Yaqoob R; Almohanadi M; Butt M; Alejji K
    World J Gastroenterol; 2012 Dec; 18(47):7003-8. PubMed ID: 23323000
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IL-28B rs12979860 C/T allele distribution in patients with liver cirrhosis: role in the course of chronic viral hepatitis and the development of HCC.
    Fabris C; Falleti E; Cussigh A; Bitetto D; Fontanini E; Bignulin S; Cmet S; Fornasiere E; Fumolo E; Fangazio S; Cerutti A; Minisini R; Pirisi M; Toniutto P
    J Hepatol; 2011 Apr; 54(4):716-22. PubMed ID: 21146242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of association between interleukin 28B gene polymorphisms (rs8099917G/T, rs12979860 C/T) and susceptibility to chronic hepatitis C virus infection, Tehran, Iran.
    Karkhane M; Mohebbi SR; Azimzadeh P; Saeedi Niasar M; Sarbazi MR; Sharifian A; Alizadeh AM
    Gastroenterol Hepatol Bed Bench; 2016 Dec; 9(Suppl1):S29-S35. PubMed ID: 28224025
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential distribution of IL28B.rs12979860 single-nucleotide polymorphism among Egyptian healthcare workers with and without a hepatitis C virus-specific cellular immune response.
    Abdelwahab SF; Zakaria Z; Sobhy M; Hamdy S; Mahmoud MA; Mikhail N; Allam WR; Rewisha E; Waked I
    Arch Virol; 2015 Jul; 160(7):1741-50. PubMed ID: 25971683
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distribution of IL28B Genotypes in Iranian Patients with Chronic Hepatitis C and Healthy Individuals.
    Sharafi H; Pouryasin A; Alavian SM; Behnava B; Keshvari M; Salimi S; Mehrnoush L; Fatemi A
    Hepat Mon; 2012 Dec; 12(12):e8387. PubMed ID: 23550102
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Programmed cell death-1
    Gatselis NK; Azariadis K; Lyberopoulou A; Dalekos GN
    J Transl Autoimmun; 2021; 4():100126. PubMed ID: 34632357
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of interferon lambda polymorphisms with elevated baseline viral loads in chronic hepatitis C virus genotype 6 infection.
    Nguyen LT; Van Nguyen D; Carr MJ; Hall WW; Nguyen LA
    Arch Virol; 2018 Jan; 163(1):115-124. PubMed ID: 29022122
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The predictive value of IL28B rs12979860, rs11881222 and rs8099917 polymorphisms and IP-10 in the therapeutic response of Egyptian genotype 4 patients.
    Derbala M; Rizk NM; Al-Kaabi S; John A; Sharma M; El-dweik N; Yakoob R; Pasic F; Almohanadi M; Alejji K; Abdelmola A; Butt M
    Virology; 2013 Sep; 444(1-2):292-300. PubMed ID: 23866096
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Strong prediction of virological response to combination therapy by IL28B gene variants rs12979860 and rs8099917 in chronic hepatitis C genotype 4.
    Ragheb MM; Nemr NA; Kishk RM; Mandour MF; Abdou MM; Matsuura K; Watanabe T; Tanaka Y
    Liver Int; 2014 Jul; 34(6):890-5. PubMed ID: 24102823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IFNL3 (IL28B) polymorphism does not predict long-term response to interferon therapy in HBeAg-positive chronic hepatitis B patients.
    Zhang Q; Lapalus M; Asselah T; Laouénan C; Moucari R; Martinot-Peignoux M; Bieche I; Estrabaud E; De Muynck S; Boyer N; Bedossa P; Vidaud M; Marcellin P; Lada O
    J Viral Hepat; 2014 Jul; 21(7):525-32. PubMed ID: 24118626
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of the recipient and donor interferon lambda-3 polymorphism on the course of HCV infection following liver transplantation.
    Wieczorek-Godlewska R; Płoski R; Perkowska-Ptasińska A; Tronina O; Sadowska A; Pacholczyk M; Lisik W; Durlik M
    Clin Exp Hepatol; 2017 Sep; 3(3):152-158. PubMed ID: 29062905
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Altered effector functions of NK cells in chronic hepatitis C are associated with IFNL3 polymorphism.
    Rogalska-Taranta M; Markova AA; Taranta A; Lunemann S; Schlaphoff V; Flisiak R; Manns MP; Cornberg M; Kraft AR; Wedemeyer H
    J Leukoc Biol; 2015 Aug; 98(2):283-94. PubMed ID: 26034208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Occult hepatitis C virus infection in hemophilia patients and its correlation with interferon lambda 3 and 4 polymorphisms.
    Nafari AH; Ayadi A; Noormohamadi Z; Sakhaee F; Vaziri F; Siadat SD; Fateh A
    Infect Genet Evol; 2020 Apr; 79():104144. PubMed ID: 31838260
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical Significance of Polymorphisms in Immune Response Genes in Hepatitis C-Related Hepatocellular Carcinoma.
    De Re V; Tornesello ML; De Zorzi M; Caggiari L; Pezzuto F; Leone P; Racanelli V; Lauletta G; Gragnani L; Buonadonna A; Vaccher E; Zignego AL; Steffan A; Buonaguro FM
    Front Microbiol; 2019; 10():475. PubMed ID: 30930876
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.